Back to Journals » OncoTargets and Therapy » Volume 2 » default
![](https://www.dovepress.com/cr_data/cache/journal_image/23/cope/thumb_100_1000_100.jpg)
OncoTargets and Therapy
ISSN: 1178-6930
- View all (6517)
- Volume 17, 2024 (79)
- Volume 16, 2023 (147)
- Volume 15, 2022 (191)
- Volume 14, 2021 (525)
- Volume 13, 2020 (1171)
- Volume 12, 2019 (1075)
- Volume 11, 2018 (882)
- Volume 10, 2017 (615)
- Volume 9, 2016 (802)
- Volume 8, 2015 (439)
- Volume 7, 2014 (253)
- Volume 6, 2013 (208)
- Volume 5, 2012 (54)
- Volume 4, 2011 (19)
- Volume 3, 2010 (22)
- Volume 2, 2009 (25)
- Volume 1, 2008 (10)
Archive: Volume 2, 2009
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Bendamustine in the treatment of non-Hodgkin’s lymphomas
Fredrick Hagemeister, George Manoukian
OncoTargets and Therapy 2009, 2:269-279
Published Date: 4 December 2009
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Safety and efficacy of sorafenib in the treatment of hepatocellular carcinoma
Khaldoun Almhanna, Philip A Philip
OncoTargets and Therapy 2009, 2:261-267
Published Date: 13 November 2009
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Rational use of cetuximab in the treatment of advanced non-small cell lung cancer
Charu Aggarwal, Hossein Borghaei
OncoTargets and Therapy 2009, 2:251-260
Published Date: 31 August 2009
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Recent results of cetuximab use in the treatment of squamous cell carcinoma of the head and neck
Francesco Perri, Francesco Longo, Franco Ionna, et al
OncoTargets and Therapy 2009, 2:243-250
Published Date: 31 August 2009
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Update on the rational use of tositumomab and iodine-131 tositumomab radioimmunotherapy for the treatment of non-Hodgkin’s lymphoma
Michael J Burdick, Roger M Macklis
OncoTargets and Therapy 2009, 2:229-242
Published Date: 19 August 2009
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Profile of nelarabine: use in the treatment of T-cell acute lymphoblastic leukemia
Kelly M Reilly, David F Kisor
OncoTargets and Therapy 2009, 2:219-228
Published Date: 6 August 2009
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Gemcitabine for the treatment of advanced nonsmall cell lung cancer
Luca Toschi, Federico Cappuzzo
OncoTargets and Therapy 2009, 2:209-217
Published Date: 3 August 2009
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Update on the rational use of (90)Y-ibritumomab tiuxetan in the treatment of follicular lymphoma
Martina Lehnert, Heinz Ludwig, Niklas Zojer
OncoTargets and Therapy 2009, 2:199-208
Published Date: 31 July 2009
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Expanded use of rituximab in the management of non-Hodgkin lymphoma
Dennis A Eichenauer, Andreas Engert, Holger Schulz
OncoTargets and Therapy 2009, 2:189-197
Published Date: 31 July 2009
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Targeted delivery of albumin bound paclitaxel in the treatment of advanced breast cancer
Francesco Di Costanzo, Silvia Gasperoni, Virginia Rotella, Federica Di Costanzo
OncoTargets and Therapy 2009, 2:179-188
Published Date: 7 July 2009
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The ubiquitin–proteasome system as a molecular target in solid tumors: an update on bortezomib
A Milano, F Perri, F Caponigro
OncoTargets and Therapy 2009, 2:171-178
Published Date: 30 June 2009
Targeting colorectal cancer with anti-epidermal growth factor receptor antibodies: focus on panitumumab
Kerry J Williams, A Craig Lockhart
OncoTargets and Therapy 2009, 2:161-170
Published Date: 30 June 2009
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Role of imatinib in the management of early, operable, and advanced GI stromal tumors (GISTs)
John T Vetto
OncoTargets and Therapy 2009, 2:151-159
Published Date: 25 June 2009
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Multiple roles and therapeutic implications of Akt signaling in cancer
Emiliano Calvo, Victoria Bolós, Enrique Grande
OncoTargets and Therapy 2009, 2:135-150
Published Date: 5 June 2009
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Targeted therapy in the treatment of malignant gliomas
Rimas V Lukas, Adrienne Boire, M Kelly Nicholas
OncoTargets and Therapy 2009, 2:115-133
Published Date: 13 May 2009
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Role of trabectedin in the treatment of soft tissue sarcoma
Alexandre Christinat, Serge Leyvraz
OncoTargets and Therapy 2009, 2:105-113
Published Date: 6 May 2009
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
The evolving role of zoledronic acid in early breast cancer
Michael Gnant
OncoTargets and Therapy 2009, 2:95-104
Published Date: 26 April 2009
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Targeted treatment of imatinib-resistant chronic myeloid leukemia: Focus on dasatinib
Charles Chuah, Junia V Melo
OncoTargets and Therapy 2009, 2:83-94
Published Date: 24 April 2009
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
First-line targeted therapies in the treatment of metastatic colorectal cancer – role of cetuximab
Giuseppe Tonini, Alice Calvieri, Bruno Vincenzi, Daniele Santini
OncoTargets and Therapy 2009, 2:73-82
Published Date: 7 April 2009
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Targeted treatment of chronic myeloid leukemia: role of imatinib
Ila Tamascar, Jeyanthi Ramanarayanan
OncoTargets and Therapy 2009, 2:63-71
Published Date: 25 March 2009
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Management of side effects associated with sunitinib therapy for patients with renal cell carcinoma
Anita Schwandt1, Laura S Wood1, Brian Rini1,2, Robert Dreicer1,2
OncoTargets and Therapy 2009, 2:51-61
Published Date: 16 March 2009
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Role of bendamustine in the treatment of chronic lymphocytic leukemia
Saad Jamshed, Bruce D Cheson
OncoTargets and Therapy 2009, 2:43-49
Published Date: 12 March 2009
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Targeting cancers in the gastrointestinal tract: role of capecitabine
Muhammad Wasif Saif
OncoTargets and Therapy 2009, 2:29-41
Published Date: 25 March 2009
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Current status of treatment of metastatic colorectal cancer with special reference to cetuximab and elderly patients
Per Pfeiffer, Camilla Qvortrup, Jon K Bjerregaard
OncoTargets and Therapy 2009, 2:17-27
Published Date: 23 December 2008
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Targeted therapies in the management of colorectal carcinoma: role of bevacizumab
Ajithkumar Puthillath, Anush Patel, Marwan G Fakih
OncoTargets and Therapy 2009, 2:1-15
Published Date: 27 November 2008